Fundz

Aurion Biotech, Inc. reported raising $11,000 in an initial SEC Form D filing, from an offering of $11,000

PRIVATEApr 21, 2022

Amount Raised

$11,000

$11,000 sold, per SEC Form D (first sale Apr 21, 2022)

Round Type

Venture

SeattleBiotechnology

Quick answer

Aurion Biotech raised $11,000 in a funding round, dated April 21, 2022. Aurion Biotech is based in Seattle, Washington, United States.

How much did Aurion Biotech raise?
Aurion Biotech raised $11,000 in a funding round on April 21, 2022.
What does Aurion Biotech do?
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness.
Where is Aurion Biotech based and how big is it?
Aurion Biotech is based in Seattle, Washington, United States. Fundz records about 92 employees.
Who are the decision-makers at Aurion Biotech?
Fundz holds 1 contact at Aurion Biotech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Aurion Biotech that raised within 45 days of this round, from Fundz verified event records.

  • GB SCIENCES raised $25K (Seed) on June 3, 2022.
  • SightStream raised an undisclosed amount on June 3, 2022.
  • RAPT Therapeutics raised $50M on June 3, 2022.
  • Enrich Biosystems raised $3.8M on June 3, 2022.
  • Vizgen raised $85M (Series C) on June 3, 2022.
  • SightStream raised $1.9M (Seed) on June 3, 2022.

Who to call at Aurion Biotech, and when

A new round usually means Aurion Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aurion Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aurion Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aurion Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aurion Biotech

Location

117 E. LOUISA STREET

Seattle, Washington, United States

About

Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aurion Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts18 people are listed at Aurion Biotech. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aurion Biotech's next move

See what Strategic adds

Aurion Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.